PriscillaArleneHollanderMD

Endocrinology • Dallas, TX

Diabetes, Lipid Metabolism

Endocrinologist, Baylor Endocrine Center

Join to view full profile

Dr. Hollander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hollander's full profile

Already have an account?

Office
3600 Gaston Ave
Suite 656
Dallas, TX 75246
Phone+1 214-820-3466

Fax+1 214-820-3468

Education & Training

University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1974 - 1977
Harvard Medical SchoolClass of 1974

Certifications & Licensure

TX State Medical License 1977 - 2025
MN State Medical License 1980 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com

Clinical Trials

A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes Start of enrollment: 2007 May 01
Completed
Phase 3
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable

Publications & Presentations

PubMed

78 citations
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
Priscilla Hollander, Jie Liu, Julie Hill, Jeremy Johnson, Zhi Wei Jiang
Diabetes Therapy. 2018-02-01
283 citations
Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with ty...
Priscilla Hollander, Alok Gupta, Raymond A Plodkowski, Frank L. Greenway, Harold Bays
Diabetes Care. 2013-12-01
11 citations
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therap...
Priscilla Hollander, Danny Sugimoto, Aleksandra Vlajnic, Charles Kilo
Journal of Diabetes and Its Complications. 2015-11-01

Press Mentions

SGLT2 Inhibitor Adds to Weight Loss with PhentermineJune 16th, 2016